Kidney Transplant; Complications Clinical Trial
Official title:
A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients
Previous studies have shown that elderly patients experience higher trough levels of tacrolimus and are more sensitive to the effects of medications, they experience higher occurrence and severity of such medication related toxicities. Therefore, the investigators hypothesize that by transitioning patients from tacrolimus immediate release to Envarsus ®, the peak-dose effect will be eliminated or attenuated, leading to a significant decrease in neurocognitive toxicities in the older patient population.
The investigators will conduct a single-center, prospective, open-label, randomized study to evaluate the difference in neurocognitive side effects between Envarsus and immediate release tacrolimus. Eligible patients will be enrolled within 8 weeks post-transplantation. They will be administered a baseline panel of neurocognitive tests. They will then be randomized to either continue on immediate release tacrolimus or Envarsus. 6 weeks after randomization, the neurocognitive tests will be repeated. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04369456 -
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
|
N/A | |
| Recruiting |
NCT06001320 -
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip
|
Early Phase 1 | |
| Withdrawn |
NCT04560582 -
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
|
||
| Not yet recruiting |
NCT05782543 -
Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion
|
N/A | |
| Completed |
NCT03996551 -
ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study
|
N/A | |
| Recruiting |
NCT05081141 -
HHV8 and Solid Organ Transplantation
|
||
| Recruiting |
NCT04508907 -
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
|
Phase 4 | |
| Not yet recruiting |
NCT06025240 -
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
|
||
| Recruiting |
NCT04713774 -
Bone Density and Vascular Calcifications Evolution After Renal Transplant
|
||
| Active, not recruiting |
NCT05483725 -
Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
|
||
| Recruiting |
NCT06095492 -
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
|
N/A | |
| Active, not recruiting |
NCT04207177 -
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
|
Phase 4 | |
| Recruiting |
NCT03410654 -
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
|
Early Phase 1 | |
| Completed |
NCT03373266 -
Serun Fluoride and Kidney Transplant
|
Phase 2 | |
| Completed |
NCT04835948 -
Efficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation
|
||
| Not yet recruiting |
NCT04514666 -
VOCs in Kidney and Liver Transplants
|
N/A | |
| Recruiting |
NCT03373500 -
Effect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant Recipients
|
N/A | |
| Recruiting |
NCT05900401 -
Delayed Tolerance Through Mixed Chimerism
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05166460 -
Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation
|
N/A | |
| Recruiting |
NCT05977387 -
Pediatric Kidney Transplant
|